New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data.
Debruyne
F M
FM
Department of Urology, University Hospital Nijmegen, The Netherlands.
Franssen
M P
MP
Beniers
A J
AJ
Schalken
J A
JA
de Mulder
P H
PH
D000328:Adult; D000368:Aged; D000818:Animals; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000628:therapy*; D004341:Drug Evaluation; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D007370:Interferon Type I / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D008875:Middle Aged; D011994:Recombinant Proteins; D014183:Transplantation, Heterologous; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D014410:Tumor Stem Cell Assay
D007155:Immunologic Factors; D007370:Interferon Type I; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma